These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Equivalence tests for shelf life and average drug content in stability studies. Djira GD; Hothorn LA; Tsong Y J Biopharm Stat; 2008; 18(5):985-95. PubMed ID: 18781530 [TBL] [Abstract][Full Text] [Related]
6. An alternative approach to evaluation of poolability for stability studies. Liu JP; Tung SC; Pong YM J Biopharm Stat; 2006; 16(1):1-14. PubMed ID: 16440833 [TBL] [Abstract][Full Text] [Related]
7. Pooling data for stability studies: testing the equality of batch degradation slopes. Ruberg SJ; Stegeman JW Biometrics; 1991 Sep; 47(3):1059-69. PubMed ID: 1742430 [TBL] [Abstract][Full Text] [Related]
8. Pooling batches in drug stability study by using constant-width simultaneous confidence bands. Liu W; Jamshidian M; Zhang Y; Bretz F; Han XL Stat Med; 2007 Jun; 26(14):2759-71. PubMed ID: 17133619 [TBL] [Abstract][Full Text] [Related]
9. Combined statistical analyses for long-term stability data with multiple storage conditions: a simulation study. Almalik O; Nijhuis MB; van den Heuvel ER J Biopharm Stat; 2014; 24(3):493-506. PubMed ID: 24697656 [TBL] [Abstract][Full Text] [Related]
11. Evaluating the performance of the ICH guidelines for shelf life estimation. Quinlan M; Stroup W; Schwenke J; Christopher D J Biopharm Stat; 2013; 23(4):881-96. PubMed ID: 23786363 [TBL] [Abstract][Full Text] [Related]
13. [Assessment of stability variation among batches, packaging, and formulations--application of matrixing and bracketing]. Yoshioka S; Aso Y; Kojima S Kokuritsu Iyakuhin Shokuhin Eisei Kenkyusho Hokoku; 1998; (116):192-4. PubMed ID: 10097539 [TBL] [Abstract][Full Text] [Related]
14. [Shelf-life estimation of pharmaceutical products by matrixing]. Yoshioka S; Aso Y; Kojima S Eisei Shikenjo Hokoku; 1996; (114):143-4. PubMed ID: 9037887 [TBL] [Abstract][Full Text] [Related]
15. Comparison of shelf-life estimates for a human insulin pharmaceutical preparation using the matrix and full-testing approaches. Oliva A; Fariña J; Llabrés M Drug Dev Ind Pharm; 2003 May; 29(5):513-21. PubMed ID: 12779281 [TBL] [Abstract][Full Text] [Related]
16. Estimation of the shelf-life of drugs with mixed effects models. Chen JJ; Hwang JS; Tsong Y J Biopharm Stat; 1995 Mar; 5(1):131-40. PubMed ID: 7613558 [TBL] [Abstract][Full Text] [Related]
17. Overview of stability study designs. Lin TY; Chen CW J Biopharm Stat; 2003 Aug; 13(3):337-54. PubMed ID: 12921386 [TBL] [Abstract][Full Text] [Related]
18. Establishment of an equivalence acceptance criterion for accelerated stability studies. Burdick RK; Sidor L J Biopharm Stat; 2013; 23(4):730-43. PubMed ID: 23799811 [TBL] [Abstract][Full Text] [Related]
19. Evaluating statistical difference, equivalence, and indeterminacy using inferential confidence intervals: an integrated alternative method of conducting null hypothesis statistical tests. Tryon WW Psychol Methods; 2001 Dec; 6(4):371-86. PubMed ID: 11778678 [TBL] [Abstract][Full Text] [Related]
20. Bayesian hierarchical modeling of drug stability data. Chen J; Zhong J; Nie L Stat Med; 2008 Jun; 27(13):2361-80. PubMed ID: 18338325 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]